Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04162119 · UNKNOWN
Trial details
- NCT number
- NCT04162119
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-07
- Primary completion
- 2021-10-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.